
Nimble is an AI-based clinical trial automation platform designed to accelerate breakthroughs in pharmaceutical and biotech research. Their platform offers a suite of AI-powered solutions including automated clinical document generation (protocols, CRFs), faster study startup by streamlining protocol development and CRF design, AI-enhanced data review and cleaning for improved data integrity, AI-driven Risk-Based Quality Management (RBQM) for proactive risk management, automated SDTM mapping for regulatory compliance, and AI-powered data visualization for deeper insights. The company aims to free research teams from tedious manual tasks, reduce administrative burden, and improve global health outcomes by bringing life-changing treatments to patients sooner. The CEO, Vineet Jain, has extensive experience in data science and machine learning within the pharmaceutical industry.

Nimble is an AI-based clinical trial automation platform designed to accelerate breakthroughs in pharmaceutical and biotech research. Their platform offers a suite of AI-powered solutions including automated clinical document generation (protocols, CRFs), faster study startup by streamlining protocol development and CRF design, AI-enhanced data review and cleaning for improved data integrity, AI-driven Risk-Based Quality Management (RBQM) for proactive risk management, automated SDTM mapping for regulatory compliance, and AI-powered data visualization for deeper insights. The company aims to free research teams from tedious manual tasks, reduce administrative burden, and improve global health outcomes by bringing life-changing treatments to patients sooner. The CEO, Vineet Jain, has extensive experience in data science and machine learning within the pharmaceutical industry.